Former FDA Com. Arthur Hull Hayes, MD
Executive Summary
Hayes will be president of EM Pharmaceuticals, the U.S. subsidiary of E. Merck (Germany). "The Pink Sheet" June 16 implied that Hayes was with the German company ("The Pink Sheet" June 16, T&G-1).